✦ LIBER ✦

Risk vs Benefit in Diabetes Pharmacotherapy: a Rational Approach to Choosing Pharmacotherapy in Type 2 Diabetes

✍ Scribed by Mary Elizabeth Cox, Mark N. Feinglos

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Key considerations in pharmacotherapy fo

✍ S. Cornell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 760 KB

Predictors of non-adherence to pharmacot

✍ Jarab, Anan S.; Almrayat, Reham; Alqudah, Salam; Thehairat, Ekbal; Mukattash, Ta 📂 Article 📅 2014 🏛 Springer Netherlands 🌐 English ⚖ 219 KB

A Pharmacotherapy Follow-Up Program in P

✍ Fornos, José A. ;Andrés, N. Floro ;Andrés, J. Carlos ;Guerra, M. Mercedes ;Egea, 📂 Article 📅 2006 🏛 Springer 🌐 Dutch ⚖ 255 KB

A Risk-Benefit Assessment of Metformin i

✍ Dr Harry C. S. Howlett, Clifford J. Bailey 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 188 KB

Effects of a pharmacotherapy follow-up i

✍ Cassyano Januário Correr; Ana Carolina Melchiors; Fernando Fernandez-Llimos; Rob 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 193 KB

Role of metformin in the initiation of p

✍ Juliana C.N. Chan; Chaicharn Deerochanawong; A. Samad Shera; Kun-Ho Yoon; John M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 574 KB